Expected to drive trauma fixation devices market expansion in the near future at a CAGR of 4.22% during the forecast period 2023 to 2032.

Market Research Future (MRFR) has published a“Global Trauma Fixation Devices Market”

MRFR recognizes the following companies as the key players in the global trauma fixation devices market— Thermo Fisher Scientific, Inc. (the US), R&D Systems (US), Abcam plc (UK), Merck KGaA (Germany), Proteintech Group, Inc. (the US), Janssen-Cilag Pty Ltd., Aviva Systems Biology, Bio-Techne Corporation (US), Elpiscience BioPharma, Eli Lilly and co., GigaGen Inc.

Trauma Fixation Devices Market Highlights

The global Trauma Fixation Devices market is accounted to register a CAGR of 4.22% during the forecast period and is estimated to reach USD 12.3 Billion by 2032.

One of the clinical methods used in trauma care, depending on the severity of the damage, is the use of trauma devices. Trauma refers to any physical injury caused by an outside force, including burns, sprains, strains, fractures, and dislocations. These methods are employed most frequently in fracture cases involving long bones.

The trauma devices can be used to treat a variety of areas, including the upper and lower extremities, the knee, joint, leg, and spine. In order to improve outcomes, polymeric materials are also being employed more commonly in trauma devices. These mostly consist of plates and screws used to repair bones. Due to the rising prevalence and incidence of bone fractures, the aging population, and the wide range of products provided by industry participants, the market for trauma fixation is anticipated to expand in the future.

Segment Analysis

The global trauma fixation devices market has been segmented into product, surgical site, material and end user.

On the basis of product, the market is segmented into external fixator devices, internal fixator devices. The internal fixator devices segment was attributed to holding the largest market share in 2022.

Based on surgical site, the global trauma fixation devices market has been segmented into upper extremities, lower extremities. The lower extremities segment was expected to hold the largest market share in 2022.

On the basis of material, the market is segmented into metallic implant, hybrid implant, bio absorbable, carbon fibre, grafts and orthobiologics. The metallic implant segment was attributed to holding the largest market share in 2022.

Based on end user, the global trauma fixation devices market has been segmented into hospitals, orthopedic surgical centers, clinics, others. The hospitals segment was expected to hold the largest market share in 2022.

Regional Analysis

The global trauma fixation devices market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe trauma fixation devices market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The trauma fixation devices market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World trauma fixation devices market comprises of Middle East, Africa, and Latin America.

The largest market share for trauma fixation devices was maintained by the North American regional sector. Over 37,000 people die in accidents each year in the United States, and 2.35 million more suffer injuries or impairments, according to the Association for Safe International Road Travel. Trauma fixation devices are in greater demand as a result. The incidence of degenerative bone disorders will have an effect on the growth of the trauma fixation device market in the United States.

The increasing prevalence and incidence of bone fractures, an aging population, and the vast range of treatments offered by industry participants are the main factors affecting the trauma fixation market's future growth in Europe. Hip fractures and other bone diseases like osteoporosis are on the rise as a result of population aging.

In Asia Pacific, the market for trauma fixation devices is currently growing, and over the next few years, it is expected to grow significantly. Additionally, this region experiences a higher number of fatalities as a result of the subpar infrastructure development. For instance, over 80% of road fatalities occur in underdeveloped countries, costing an estimated USD 65 billion annually, according to the Association for Safe International Road Travel.

The Middle East and Africa are expected to experience economic growth, opening the door to attractive development opportunities. In recent years, the Middle East and Africa have had the highest number of road deaths. The market is expanding as a result of factors like the aging population in the Middle East and Africa, growing use of minimally invasive surgery, and an increase in traffic accidents and injuries.

Key Findings of the Study

• The global trauma fixation devices market is expected to reach USD 12.3 Billion by 2032, at a CAGR of 4.22% during the forecast period.


• The Asia Pacific region accounted for the fastest-growing global market due to increasing prevalence and incidence of road accidents every year


• Based on product, the internal fixator devices segment was attributed to holding the largest market in 2022, with an approximate market share of 68.54%.


• Thermo Fisher Scientific, Inc. (the US), R&D Systems (US), Abcam plc (UK), Merck KGaA (Germany), Proteintech Group, Inc. (the US), Janssen-Cilag Pty Ltd., Aviva Systems Biology, Bio-Techne Corporation (US), Elpiscience BioPharma, Eli Lilly and co., GigaGen Inc.